PER 7.50% 8.6¢ percheron therapeutics limited

Ann: ATL1103 Phase II Trial - Successful Efficacy Results, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,755 Posts.
    lightbulb Created with Sketch. 554
    So that's the big question do they have a partner or funding lined up for the Phase III ?

    A pretty big or indicative statement to make of moving to a Phase III trial with $1.3M in the bank as of 8 weeks ago ?

    Not to sure what to make of this though ? Is a partner there or they are waiting for one ?

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
0.006(7.50%)
Mkt cap ! $89.16M
Open High Low Value Volume
8.3¢ 8.9¢ 8.1¢ $294.9K 3.491M

Buyers (Bids)

No. Vol. Price($)
1 49999 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 16887 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.